(Q41631306)

English

Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study

scientific article published on 2 January 2015

Statements

Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study (English)
2 January 2015
1121-1129

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit